Cargando…

The furosemide stress test to predict renal function after continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	van der Voort, Peter HJ, Boerma, E Christiaan, Pickkers, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057371/ https://www.ncbi.nlm.nih.gov/pubmed/25033085 http://dx.doi.org/10.1186/cc13871

Ejemplares similares

Role of the Furosemide Stress Test in Renal Injury Prognosis
por: Coca, Armando, et al.
Publicado: (2020)

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis
por: Chen, Jia-Jin, et al.
Publicado: (2020)

The furosemide stress test predicts the timing of continuous renal replacement therapy initiation in critically ill patients with acute kidney injury: a double-blind prospective intervention cohort study
por: Zhang, Kun, et al.
Publicado: (2023)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Furosemide Stress Test and Renal Resistive Index for Prediction of Severity of Acute Kidney Injury in Sepsis
por: Das, Pravin K, et al.
Publicado: (2023)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019)

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
por: Meersch, Melanie, et al.
Publicado: (2023)

A Furosemide Excretion Stress Test Predicts Mortality in Mice After Sepsis and Outperforms the Furosemide Stress Test During Vasopressin Administration
por: Street, Jonathan M., et al.
Publicado: (2020)

Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial)
por: Lumlertgul, Nuttha, et al.
Publicado: (2018)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Early mobilization on continuous renal replacement therapy is safe and may improve filter life
por: Jacobs, Frederic M
Publicado: (2015)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy
por: Kiers, H. D., et al.
Publicado: (2011)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Data-driven prediction of continuous renal replacement therapy survival
por: Bui, Alex, et al.
Publicado: (2023)

Ultrafiltration rate is an important determinant of microcirculatory alterations during chronic renal replacement therapy
por: Veenstra, Gerke, et al.
Publicado: (2017)

Predicting the requirement for renal replacement therapy in intensive care patients with sepsis
por: Nierhaus, Axel, et al.
Publicado: (2018)

Variation of High-Sensitivity Troponin T Results in Patients Undergoing Continuous Renal Replacement Therapy
por: Srinivasan Sridhar, Vikas, et al.
Publicado: (2019)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal replacement therapy in severe COVID-19 patients: Intermittent or continuous, the ongoing debate
por: Gaudray, Eliott, et al.
Publicado: (2021)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Clarifications on Continuous Renal Replacement Therapy and Hemodynamics
por: Wang, Xiao-Ting, et al.
Publicado: (2017)

Continuous Renal Replacement Therapy in Preterm Infants
por: Noh, Eu Seon, et al.
Publicado: (2019)

Basics of continuous renal replacement therapy in pediatrics
por: John, Jacob C., et al.
Publicado: (2019)

Renal long-term outcome of critically ill COVID-19 patients with acute kidney failure and continuous renal replacement therapy
por: Melero, Rosa, et al.
Publicado: (2021)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
por: Zheng, Zhigui, et al.
Publicado: (2021)

Early versus late renal replacement therapy in acute kidney injury: the search for a definition of timing continues
por: Bannard-Smith, Jonathan, et al.
Publicado: (2011)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_djn41589hufrrs1sjge1ct1uu7